Golden State Equity Partners’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,250
Closed -$28.3K 731
2024
Q3
$28.3K Buy
+3,250
New +$28.3K 0.01% 469
2022
Q1
$259K Buy
52,250
+100
+0.2% +$496 0.13% 158
2021
Q4
$363K Buy
52,150
+19,890
+62% +$138K 0.18% 110
2021
Q3
$323K Buy
32,260
+18,860
+141% +$189K 0.13% 154
2021
Q2
$190K Buy
+13,400
New +$190K 0.07% 229